| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |